[The labelling index as a prognostic marker in breast carcinoma].
In this work assess the labelling index in sixty patients affected by breast cancer and treated with only local surgical therapy, without subsequent chemo- or radiotherapy. We had considered L.I. a single prognostic factor and in relation with other common prognostic factors of this neoplasia. The patients with a high L.I. have shown a greater probability of relapses, also in absence of lymph nodal metastases.
Bisail
M
M
Cattedra di Oncologia Clinica, Università di Sassari.
Nieddu
S
S
Sarobba
M G
MG
Sanna
G
G
Milia
V
V
Ghì
M G
MG
Farris
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001345:Autoradiography; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D018275:Carcinoma, Lobular / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000473:pathology; D011379:Prognosis; D013936:Thymidine
D014408:Biomarkers, Tumor; D013936:Thymidine
Labelling index come marker prognostico nel carcinoma della mammella.